Autolus Therapeutics Q1 EPS $(0.24) Compared With $(0.23) YoY, Quarterly Sales Totals $10.09M, Exits Quarter With Cash & Equivalents Worth $758.5M
Portfolio Pulse from Benzinga Newsdesk
Autolus Therapeutics (NASDAQ:AUTL) reported a Q1 EPS of $(0.24), compared to $(0.23) year-over-year, with quarterly sales totaling $10.09M. The company exited the quarter with $758.5M in cash and equivalents.
May 17, 2024 | 11:10 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Autolus Therapeutics reported a slight increase in quarterly losses with an EPS of $(0.24) compared to $(0.23) YoY. However, the company has a strong cash position with $758.5M in cash and equivalents.
The slight increase in losses may concern some investors, but the strong cash position provides a buffer. The overall impact on the stock price is likely to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100